Daniel Sharp
Directeur/Membre du Conseil chez ALCIDION GROUP LIMITED
Fortune : 488 743 $ au 30/04/2024
Profil
Daniel Sharp is currently a Non-Executive Director at Botanix Pharmaceuticals Ltd.
and an Independent Non-Executive Director at Alcidion Group Ltd.
He previously served as an Independent Non-Executive Director at ImpediMed Ltd.
in 2023, an Executive Director at Shaw & Partners Corporate Finance Pty Ltd., and an Executive Director at Canaccord Genuity (Australia) Ltd.
from 2012 to 2020.
He also served as an Independent Non-Executive Director at Race Oncology Ltd.
in 2022-2023.
Mr. Sharp received his undergraduate and graduate degrees from Monash University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMPEDIMED LIMITED
0,41% | 28/09/2023 | 8 234 192 ( 0,41% ) | 449 175 $ | 30/04/2024 |
ALCIDION GROUP LIMITED
0,08% | 30/06/2023 | 1 128 572 ( 0,08% ) | 39 568 $ | 30/04/2024 |
Postes actifs de Daniel Sharp
| Sociétés | Poste | Début |
|---|---|---|
| ALCIDION GROUP LIMITED | Directeur/Membre du Conseil | 01/09/2021 |
| BOTANIX PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 22/03/2022 |
Anciens postes connus de Daniel Sharp
| Sociétés | Poste | Fin |
|---|---|---|
| IMPEDIMED LIMITED | Directeur/Membre du Conseil | 28/09/2023 |
| RACE ONCOLOGY LIMITED | Directeur/Membre du Conseil | 29/06/2023 |
Canaccord Genuity (Australia) Ltd.
 Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Canaccord Genuity (Australia) Ltd. (Canaccord Genuity Australia) is the Australian full service stockbroking and wealth management subsidiary of Canaccord Genuity Group Inc. (TSE: CF) in Canada. Headquartered in Melbourne, Canaccord Genuity Australia was founded by Anthony Murphy and provides wealth management services including portfolio management, portfolio administration and broking services to individual, institutional and corporate clients. | Directeur/Membre du Conseil | 01/01/2020 |
Shaw & Partners Corporate Finance Pty Ltd.
 Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Part of EFG International AG, Shaw & Partners Corporate Finance Pty Ltd. is a brokerage firm founded in 1987. The private company is based in Sydney, Australia and provides brokerage services. | Corporate Officer/Principal | - |
Formation de Daniel Sharp
| Monash University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ALCIDION GROUP LIMITED | Technology Services |
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| RACE ONCOLOGY LIMITED | Health Technology |
| IMPEDIMED LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shaw & Partners Corporate Finance Pty Ltd.
Shaw & Partners Corporate Finance Pty Ltd. Investment Banks/BrokersFinance Part of EFG International AG, Shaw & Partners Corporate Finance Pty Ltd. is a brokerage firm founded in 1987. The private company is based in Sydney, Australia and provides brokerage services. | Finance |
Canaccord Genuity (Australia) Ltd.
Canaccord Genuity (Australia) Ltd. Investment Banks/BrokersFinance Canaccord Genuity (Australia) Ltd. (Canaccord Genuity Australia) is the Australian full service stockbroking and wealth management subsidiary of Canaccord Genuity Group Inc. (TSE: CF) in Canada. Headquartered in Melbourne, Canaccord Genuity Australia was founded by Anthony Murphy and provides wealth management services including portfolio management, portfolio administration and broking services to individual, institutional and corporate clients. | Finance |
